Sirachat Nitchaphanit

Sirachat Nitchaphanit

Auto-generated profile, based on publicly available information

Sirachat Nitchaphanit


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Materials Today Communications
Verified
Journal Article
Closed access
AKApinya Krainoi
Apinya Krainoi
WPWatcharamon Prasert
Watcharamon Prasert
PKPiyanate Kesakomol
Piyanate Kesakomol
PTPimwan Thongdee
Pimwan Thongdee
SNSirachat Nitchaphanit
Sirachat Nitchaphanit
Yeampon NakaramontriYeampon Nakaramontri
Yeampon Nakaramontri

5 January 2025 in Journal of Associated Medical Sciences
Verified
Journal Article
Closed access
PTPimwan Thongdee
Pimwan Thongdee
PNPutt Narongdej
Putt Narongdej
PWPassara Wongthai
Passara Wongthai
SNSirachat Nitchaphanit
Sirachat Nitchaphanit
KCKasidach Chuenchom
Kasidach Chuenchom
TBTanit Boonsiri
Tanit Boonsiri
Background: Antimicrobial resistance (AMR) is a major public health problem worldwide, and it is increasing, especially in developed and developing countries, including Thailand. Sepsis is a crisis and emergency causing the death of patients with a high mortality rate of 1 in 5 of the global population. Using inappropriate antimicrobial drugs to treat infections increases the chance of drug resistance in the microorganisms, and precise and rapid treatment is essential for patient management. Objective: This cooperative study aims to evaluate a commercial multiplex real-time PCR panel, QIAstat-Dx BCID GN Plus AMR Panel, to detect antimicrobial-resistant genes in the bloodstream. Materials and methods: Thirty bacterial samples were used to simulate bloodstream infections. The comparison between the QIAstat-Dx BCID GN Plus AMR Panel and the conventional PCR method was revealed. Results: Both methods gave concordant results for 12 samples, while results for 15 were discordant. Three samples could not be detected using the QIAstat-Dx BCID GN Plus AMR Panel because ebc gene is not included. The QIAstat-Dx BCID GN Plus AMR Panel revealed a sensitivity, specificity, positive predictive value, and negative predictive value of 91.50%, 93.30%, 74.10%, and 98.50%, respectively. Conclusion: The study indicated that the QIAstat-Dx BCID GN Plus AMR Panel Cartridge can detect common antimicrobial-resistant genes from the bloodstream. However, additional resistant genes should be included in the panel to cover various highly prevalent antimicrobial-resistant genes based on geographical location.